~~<i id='6A1E126A8B'><strike id='6A1E126A8B'><tt id='6A1E126A8B'><pre id='6A1E126A8B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：comprehensive 2025-10-01 12:11:21 - browse：7

The FDA building -- First Opinion coverage from STAT — Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Lifetime voting ban for felony convictions struck down in Mississippi

focus

knowledge

Wikipedia

entertainment

focus

PhotobyKEREMYUCEL/AFPviaGettyImagesSANFRANCISCO—MayoClinichassignedSiliconValleytechstartupCerebrasa

WSS

Russian court extends detention of American musician

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Special counsel alerts court to Trump’s social media post

FDA early review: GLP

hotspot

entertainment

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Wildfire smoke exposes gaps in outdoor worker protections

Medicare Advantage overpayments discussion gets experts fired up

Psychedelics group wrestles with new pharma identity

Arena BioWorks launches in Cambridge to speed drug discovery

Cancer drug shortages should be causing more outrage

Boston Scientific acquires urology company Axonics for $3.7 billion

Medical records are filled with copy

'Cuddling' is just what the doctor ordered for a 200

focus

Merck to acquire Harpoon Therapeutics for $680 million

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

Study suggests new cause of Down syndrome: cells linked to aging

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Climate activists disrupt London Pride march to protest corporate sponsorship

Lifetime voting ban for felony convictions struck down in Mississippi

knowledge

Wikipedia

entertainment

focus